Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 4 | 0 | 2 | 0 | €27.19 | - | - |
| Bayer AG | 15 | 1 | 1 | 0 | €26.98 | €50.00 | 85.357% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €283.00 | - | - |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €99.70 | €110.00 | 10.331% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €49.30 | €57.50 | 16.633% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 6 | 0 | 1 | 0 | €36.24 | €95.00 | 162.141% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €37.81 | €48.50 | 28.273% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €139.85 | €165.00 | 17.984% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €91.53 | €99.50 | 8.708% |
| GSK plc | 1 | 0 | 0 | 0 | €19.14 | - | - |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €136.86 | €196.74 | 43.750% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €460.40 | €543.72 | 18.097% |
| Merck & Co. Inc. | 27 | 1 | 4 | 0 | €121.80 | €124.92 | 2.558% |
| Align Technology | 15 | 2 | 4 | 0 | €289.40 | €345.95 | 19.540% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €251.15 | €294.28 | 17.174% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 7 | 1 | €830.20 | €957.22 | 15.300% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €370.80 | €382.71 | 3.211% |
| Stratec SE | 2 | 0 | 0 | 0 | €39.60 | - | - |